Specialty pharmaceutical company ULURU has introduced Altrazeal in a 0.75gm blister pack targeting US chronic wound market. New packaging system provides information regarding appropriate quantity for the treatment of chronic wounds and ...
Tags: ULURU, blister pack, pharmaceutical company
Pharmaceutical company in the US, ULURU has completed the initial production of the Altrazeal 0.75g transparent blister pack. The Altrazeal 0.75g blister pack, which completed test marketing in the US and Europe, incorporates an ...
Tags: ULURU, CEO, smaller chronic wounds